Cargando…

Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA

The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s–1990s; however, candidiasis accompanyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Poowanawittayakom, Nongnooch, Dutta, Anamika, Stock, Shannon, Touray, Sunkaru, Ellison, Richard T., Levitz, Stuart M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875264/
https://www.ncbi.nlm.nih.gov/pubmed/29553923
http://dx.doi.org/10.3201/eid2404.171807
_version_ 1783310333450911744
author Poowanawittayakom, Nongnooch
Dutta, Anamika
Stock, Shannon
Touray, Sunkaru
Ellison, Richard T.
Levitz, Stuart M.
author_facet Poowanawittayakom, Nongnooch
Dutta, Anamika
Stock, Shannon
Touray, Sunkaru
Ellison, Richard T.
Levitz, Stuart M.
author_sort Poowanawittayakom, Nongnooch
collection PubMed
description The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s–1990s; however, candidiasis accompanying IVDU became considerably rarer as the purity of the heroin supply increased. We reviewed cases of candidemia occurring over a recent 7-year period in persons >14 years of age at a tertiary care hospital in central Massachusetts. Of the 198 patients with candidemia, 24 cases occurred in patients with a history of IVDU. Compared with non-IVDU patients, those with a history of IVDU were more likely to have non-albicans Candida, be co-infected with hepatitis C, and have end-organ involvement, including endocarditis and osteomyelitis. Thus, IVDU appears to be reemerging as a risk factor for invasive candidiasis.
format Online
Article
Text
id pubmed-5875264
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-58752642018-04-06 Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA Poowanawittayakom, Nongnooch Dutta, Anamika Stock, Shannon Touray, Sunkaru Ellison, Richard T. Levitz, Stuart M. Emerg Infect Dis Synopsis The epidemic of illicit intravenous drug use (IVDU) in the United States has been accompanied by a surge in drug overdose deaths and infectious sequelae. Candida albicans infections were associated with injection of contaminated impure brown heroin in the 1970s–1990s; however, candidiasis accompanying IVDU became considerably rarer as the purity of the heroin supply increased. We reviewed cases of candidemia occurring over a recent 7-year period in persons >14 years of age at a tertiary care hospital in central Massachusetts. Of the 198 patients with candidemia, 24 cases occurred in patients with a history of IVDU. Compared with non-IVDU patients, those with a history of IVDU were more likely to have non-albicans Candida, be co-infected with hepatitis C, and have end-organ involvement, including endocarditis and osteomyelitis. Thus, IVDU appears to be reemerging as a risk factor for invasive candidiasis. Centers for Disease Control and Prevention 2018-04 /pmc/articles/PMC5875264/ /pubmed/29553923 http://dx.doi.org/10.3201/eid2404.171807 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Poowanawittayakom, Nongnooch
Dutta, Anamika
Stock, Shannon
Touray, Sunkaru
Ellison, Richard T.
Levitz, Stuart M.
Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA
title Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA
title_full Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA
title_fullStr Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA
title_full_unstemmed Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA
title_short Reemergence of Intravenous Drug Use as Risk Factor for Candidemia, Massachusetts, USA
title_sort reemergence of intravenous drug use as risk factor for candidemia, massachusetts, usa
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875264/
https://www.ncbi.nlm.nih.gov/pubmed/29553923
http://dx.doi.org/10.3201/eid2404.171807
work_keys_str_mv AT poowanawittayakomnongnooch reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa
AT duttaanamika reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa
AT stockshannon reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa
AT touraysunkaru reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa
AT ellisonrichardt reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa
AT levitzstuartm reemergenceofintravenousdruguseasriskfactorforcandidemiamassachusettsusa